HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Response to nimotuzumab in a child with a progressive diffuse intrinsic pontine glioma.

AuthorsMaría Elena Mateos, Eduardo López-Laso, Lucía Izquierdo, Juan Luis Pérez-Navero, Sonia García, Cruces Garzás
JournalPediatrics international : official journal of the Japan Pediatric Society (Pediatr Int) Vol. 53 Issue 2 Pg. 261-3 (Apr 2011) ISSN: 1442-200X [Electronic] Australia
PMID21501315 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Alkylating
  • nimotuzumab
  • Dacarbazine
  • ErbB Receptors
  • Temozolomide
Topics
  • Antibodies, Monoclonal (administration & dosage, therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Alkylating (administration & dosage, therapeutic use)
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
  • Brain Stem Neoplasms (drug therapy, metabolism, radiotherapy)
  • Child
  • Dacarbazine (administration & dosage, analogs & derivatives, therapeutic use)
  • Disease Progression
  • ErbB Receptors (metabolism)
  • Humans
  • Infusions, Intravenous
  • Magnetic Resonance Imaging
  • Male
  • Pons
  • Temozolomide

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: